DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Yasuda S, Sho M, Yamato I. et al.
Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo.
Clin Exp Immunol 2013;
172: 500-506
DOI: 10.1111/cei.12069. (PMID: 23600839)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.